These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 23788470

  • 1. Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
    Wadhawan M, Gupta S, Goyal N, Taneja S, Kumar A.
    Liver Transpl; 2013 Sep; 19(9):1030-5. PubMed ID: 23788470
    [Abstract] [Full Text] [Related]

  • 2. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
    Gane EJ, Patterson S, Strasser SI, McCaughan GW, Angus PW.
    Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403
    [Abstract] [Full Text] [Related]

  • 3. Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
    Choudhary NS, Saraf N, Saigal S, Mohanka R, Rastogi A, Goja S, Menon PB, Soin AS.
    Transpl Infect Dis; 2015 Jun; 17(3):329-33. PubMed ID: 25682715
    [Abstract] [Full Text] [Related]

  • 4. Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
    Karlas T, Hartmann J, Weimann A, Maier M, Bartels M, Jonas S, Mössner J, Berg T, Tillmann HL, Wiegand J.
    Transpl Infect Dis; 2011 Jun; 13(3):299-302. PubMed ID: 21159112
    [Abstract] [Full Text] [Related]

  • 5. Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective.
    Wesdorp DJ, Knoester M, Braat AE, Coenraad MJ, Vossen AC, Claas EC, van Hoek B.
    J Clin Virol; 2013 Sep; 58(1):67-73. PubMed ID: 23880162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.
    Khemichian S, Hsieh MJ, Zhang SR, Limurti J, Kim J, Fong TL.
    Dig Dis Sci; 2015 Sep; 60(9):2807-12. PubMed ID: 25939541
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients.
    Fernández I, Loinaz C, Hernández O, Abradelo M, Manrique A, Calvo J, Manzano M, García A, Cambra F, Castellano G, Jiménez C.
    Transpl Infect Dis; 2015 Oct; 17(5):695-701. PubMed ID: 26257166
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y, Marusawa H, Egawa H, Okamoto S, Ogura Y, Oike F, Nishijima N, Takada Y, Uemoto S, Chiba T.
    Antivir Ther; 2011 Oct; 16(4):479-87. PubMed ID: 21685535
    [Abstract] [Full Text] [Related]

  • 16. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
    Shen S, Jiang L, Xiao GQ, Yan LN, Yang JY, Wen TF, Li B, Wang WT, Xu MQ, Wei YG.
    World J Gastroenterol; 2015 Jan 14; 21(2):584-92. PubMed ID: 25593480
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.
    Singer GA, Zielsdorf S, Fleetwood VA, Alvey N, Cohen E, Eswaran S, Shah N, Chan EY, Hertl M, Fayek SA.
    Transplant Proc; 2015 Mar 14; 47(2):478-84. PubMed ID: 25769595
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.